Skip to Content

Network model of survival signaling in large granular lymphocyte leukemia.

TitleNetwork model of survival signaling in large granular lymphocyte leukemia.
Publication TypeJournal Article
Year of Publication2008
AuthorsZhang R, Shah MV, Yang J, Nyland SB, Liu X, Yun JK, Albert R, Loughran TP
JournalProceedings of the National Academy of Sciences of the United States of America
Date Published2008 Oct 21
KeywordsAdaptor Proteins, Signal Transducing, Humans, Interleukin-15, Leukemia, Large Granular Lymphocytic, Models, Biological, NF-kappa B, Platelet-Derived Growth Factor, Signal Transduction, STAT3 Transcription Factor, Tumor Cells, Cultured

T cell large granular lymphocyte (T-LGL) leukemia features a clonal expansion of antigen-primed, competent, cytotoxic T lymphocytes (CTL). To systematically understand signaling components that determine the survival of CTL in T-LGL leukemia, we constructed a T-LGL survival signaling network by integrating the signaling pathways involved in normal CTL activation and the known deregulations of survival signaling in leukemic T-LGL. This network was subsequently translated into a predictive, discrete, dynamic model. Our model suggests that the persistence of IL-15 and PDGF is sufficient to reproduce all known deregulations in leukemic T-LGL. This finding leads to the following predictions: (i) Inhibiting PDGF signaling induces apoptosis in leukemic T-LGL. (ii) Sphingosine kinase 1 and NFkappaB are essential for the long-term survival of CTL in T-LGL leukemia. (iii) NFkappaB functions downstream of PI3K and prevents apoptosis through maintaining the expression of myeloid cell leukemia sequence 1. (iv) T box expressed in T cells (T-bet) should be constitutively activated concurrently with NFkappaB activation to reproduce the leukemic T-LGL phenotype. We validated these predictions experimentally. Our study provides a model describing the signaling network involved in maintaining the long-term survival of competent CTL in humans. The model will be useful in identifying potential therapeutic targets for T-LGL leukemia and generating long-term competent CTL necessary for tumor and cancer vaccine development.

Alternate JournalProc. Natl. Acad. Sci. U.S.A.

biblio | about seo